---
reference_id: "PMID:39301863"
title: Upadacitinib shows efficacy in Netherton syndrome with poor response to Dupilumab.
authors:
- Li H
- Wang J
journal: J Dermatol
year: '2025'
doi: 10.1111/1346-8138.17461
content_type: abstract_only
---

# Upadacitinib shows efficacy in Netherton syndrome with poor response to Dupilumab.
**Authors:** Li H, Wang J
**Journal:** J Dermatol (2025)
**DOI:** [10.1111/1346-8138.17461](https://doi.org/10.1111/1346-8138.17461)

## Content

1. J Dermatol. 2025 Feb;52(2):e172-e173. doi: 10.1111/1346-8138.17461. Epub 2024 
Sep 20.

Upadacitinib shows efficacy in Netherton syndrome with poor response to 
Dupilumab.

Li H(1), Wang J(2).

Author information:
(1)Department of Dermatology, The First Affiliated Hospital, College of Clinical 
Medicine of Henan University of Science and Technology, Luoyang, China.
(2)Department of Dermatology, Henan Provincial People's Hospital, Zhengzhou 
University People's Hospital, Henan University People's Hospital, Zhengzhou, 
China.

DOI: 10.1111/1346-8138.17461
PMID: 39301863